Volume 5, Issue 3 p. 166-181
Research article

UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse

Masato Okano

Corresponding Author

Masato Okano

Anti-Doping Laboratory, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo, 174-8555 Japan

Correspondence to: Masato Okano, Anti-Doping Laboratory, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku Tokyo, 174–8555, Japan.

E-mail: [email protected]

Search for more papers by this author
Toshihiko Ueda

Toshihiko Ueda

Advanced Medical Science Research Center, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo, 174-8555 Japan

Search for more papers by this author
Yasunori Nishitani

Yasunori Nishitani

Anti-Doping Laboratory, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo, 174-8555 Japan

Search for more papers by this author
Hiroko Kano

Hiroko Kano

Anti-Doping Laboratory, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo, 174-8555 Japan

Search for more papers by this author
Ayako Ikekita

Ayako Ikekita

Anti-Doping Laboratory, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo, 174-8555 Japan

Search for more papers by this author
Shinji Kageyama

Shinji Kageyama

Anti-Doping Laboratory, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo, 174-8555 Japan

Search for more papers by this author
First published: 09 August 2012
Citations: 34

Abstract

Ethnicity has been found to influence urinary testosterone glucuronide to epitestosterone glucuronide (T/E) ratios among athletes. Uridine diphospho-glucuronosyltransferase 2B17 (UGT2B17) is the most active enzyme in testosterone glucuronidation. UGT2B17 polymorphism analysis is rarely performed in Japanese athletes, and the influence of testosterone administration on steroid profiles and carbon isotope ratios, according to gene polymorphisms, in Asians remains unknown. The prevalence of UGT2B17 genotypes and urinary androgenic steroid profiles, classified according to UGT2B17 genotypes, was investigated in Japanese athletes (255 male and 256 female). Testosterone enanthate (100 mg) was administered intramuscularly to Japanese female volunteers (del/del: n = 6, del/ins: n = 3, ins/ins: n = 1). The distribution rates of the UGT2B17 del/del genotype in Japanese male and female athletes were 74.5% and 60.2%, respectively. The ins/ins genotype was detected in only three male (1.2%) and seven female (2.7%) athletes. The prevalence of the UGT2B17 deletion genotype was extremely high in Japanese athletes. The T/E ratio in the del/del group was significantly lower than that in the other groups. After testosterone was administered to female volunteers, the T/E ratios for the del/del individuals failed to reach the positivity criterion of 4. By contrast, in all of the del/del subjects, the gas chromatography/combustion/isotope ratio mass spectrometry (GC-C-IRMS) analysis successfully fulfilled the positivity criterion. The overall result has demonstrated the limited effectiveness of population-based T/E ratios in screening tests for testosterone use. Subject-based steroid profiling with UGT2B17 genotyping will be an effective strategy for detecting testosterone misuse. Copyright © 2012 John Wiley & Sons, Ltd.